Titan Pharmaceuticals Inc (TTNP)

[KMBJN]

Interesting article about expanding prescribing of buprenorphine:

http://journals.lww.com/practicalpsychiatry/Fulltext/2016/05000/Buprenorphine_Prescribing___To_Expand_or_Not_to.4.aspx

Unfortunately, no mention of probuphine implant.

However, how exciting it is to see all these media articles acknowledging that FDA approval should be coming soon. I don't see how the FDA could possibly ignore the science (again), their own ADCom (again), new political pressure, and especially now all the media noise about the opioid epidemic, and reject probuphine again.

Sounds like they are just discussing appropriate labeling, and Braeburn is ready for launch, with the stock price to tag along nicely, IMO. Most importantly, this drug will really help a lot of people, and is sorely needed. I doubt FDA will approve it early, but one never knows what they will do. It's hard not to get too excited and buy more (I'm at my 5% of portfolio individual stock holding max already).